127 related articles for article (PubMed ID: 11407522)
1. Association of enhanced cyclooxygenase-2 expression with possible local immunosuppression in human colorectal carcinomas.
Kojima M; Morisaki T; Uchiyama A; Doi F; Mibu R; Katano M; Tanaka M
Ann Surg Oncol; 2001 Jun; 8(5):458-65. PubMed ID: 11407522
[TBL] [Abstract][Full Text] [Related]
2. Involvement of cyclooxygenase-2 in interleukin-1alpha-induced prostaglandin production by human periodontal ligament cells.
Noguchi K; Shitashige M; Ishikawa I
J Periodontol; 1999 Aug; 70(8):902-8. PubMed ID: 10476899
[TBL] [Abstract][Full Text] [Related]
3. Inhibited proliferation of cyclooxygenase-2 expressing human hepatoma cells by NS-398, a selective COX-2 inhibitor.
Hu KQ; Yu CH; Mineyama Y; McCracken JD; Hillebrand DJ; Hasan M
Int J Oncol; 2003 Apr; 22(4):757-63. PubMed ID: 12632065
[TBL] [Abstract][Full Text] [Related]
4. Cyclooxygenase-2-dependent prostaglandin E2 down-regulates intercellular adhesion molecule-1 expression via EP2/EP4 receptors in interleukin-1beta-stimulated human gingival fibroblasts.
Noguchi K; Iwasaki K; Shitashige M; Endo H; Kondo H; Ishikawa I
J Dent Res; 2000 Dec; 79(12):1955-61. PubMed ID: 11201045
[TBL] [Abstract][Full Text] [Related]
5. Apoptosis induction and cyclooxygenase-2 regulation in human colorectal adenoma and carcinoma cell lines by the cyclooxygenase-2-selective non-steroidal anti-inflammatory drug NS-398.
Elder DJ; Halton DE; Crew TE; Paraskeva C
Int J Cancer; 2000 May; 86(4):553-60. PubMed ID: 10797271
[TBL] [Abstract][Full Text] [Related]
6. The effect of selective cyclooxygenase inhibitors on intestinal epithelial cell mitogenesis.
Erickson BA; Longo WE; Panesar N; Mazuski JE; Kaminski DL
J Surg Res; 1999 Jan; 81(1):101-7. PubMed ID: 9889067
[TBL] [Abstract][Full Text] [Related]
7. Expression of cyclooxygenase-2 protein in colorectal carcinomas.
Joo YE; Kim HS; Min SW; Lee WS; Park CH; Park CS; Choi SK; Rew JS; Kim SJ
Int J Gastrointest Cancer; 2002; 31(1-3):147-54. PubMed ID: 12622426
[TBL] [Abstract][Full Text] [Related]
8. Expression of COX-2 in stomach cancers and its relation to their biological features.
Han SL; Tang HJ; Hua YW; Ji SQ; Lin DX
Dig Surg; 2003; 20(2):107-14. PubMed ID: 12686777
[TBL] [Abstract][Full Text] [Related]
9. Expression of cyclooxygenase-1 and -2 in urinary bladder carcinomas in vivo and in vitro and prostaglandin E2 synthesis in cultured bladder cancer cells.
Boström PJ; Aaltonen V; Söderström KO; Uotila P; Laato M
Pathology; 2001 Nov; 33(4):469-74. PubMed ID: 11827414
[TBL] [Abstract][Full Text] [Related]
10. Involvement of cyclooxygenase-2 in serum-induced prostaglandin production by human oral gingival epithelial cells.
Noguchi K; Shitashige M; Endo H; Kondo H; Yotsumoto Y; Izumi Y; Nitta H; Ishikawa I
J Periodontal Res; 2001 Apr; 36(2):124-30. PubMed ID: 11327079
[TBL] [Abstract][Full Text] [Related]
11. Cyclooxygenase-2-dependent prostaglandin production by peripheral blood monocytes stimulated with lipopolysaccharides isolated from periodontopathogenic bacteria.
Noguchi K; Yanai M; Shitashige M; Nishihara T; Ishikawa I
J Periodontol; 2000 Oct; 71(10):1575-82. PubMed ID: 11063390
[TBL] [Abstract][Full Text] [Related]
12. Specific inhibition of cyclooxygenase-2 results in inhibition of proliferation of oral cancer cell lines via suppression of prostaglandin E2 production.
Sumitani K; Kamijo R; Toyoshima T; Nakanishi Y; Takizawa K; Hatori M; Nagumo M
J Oral Pathol Med; 2001 Jan; 30(1):41-7. PubMed ID: 11140899
[TBL] [Abstract][Full Text] [Related]
13. Nuclear factor-kappa B regulates cyclooxygenase-2 expression and cell proliferation in human colorectal carcinoma tissue.
Yu LL; Yu HG; Yu JP; Luo HS
Eksp Onkol; 2004 Mar; 26(1):40-7. PubMed ID: 15112579
[TBL] [Abstract][Full Text] [Related]
14. Effects of platelet activating factor, butyrate and interleukin-6 on cyclooxygenase-2 expression in human esophageal cancer cells.
Wang LS; Chow KC; Wu YC
Scand J Gastroenterol; 2002 Apr; 37(4):467-75. PubMed ID: 11989839
[TBL] [Abstract][Full Text] [Related]
15. Participation of cyclooxygenase-1 in prostaglandin E2 release from synovitis tissue in primary osteoarthritis in vitro.
Knorth H; Dorfmüller P; Lebert R; Schmidt WE; Wittenberg RH; Heukamp M; Wiese M; Willburger RE
Osteoarthritis Cartilage; 2004 Aug; 12(8):658-66. PubMed ID: 15262246
[TBL] [Abstract][Full Text] [Related]
16. NS-398, a selective cyclooxygenase 2 inhibitor, inhibited cell growth and induced cell cycle arrest in human hepatocellular carcinoma cell lines.
Cheng J; Imanishi H; Amuro Y; Hada T
Int J Cancer; 2002 Jun; 99(5):755-61. PubMed ID: 12115513
[TBL] [Abstract][Full Text] [Related]
17. The potential for a selective cyclooxygenase-2 inhibitor in the prevention of liver metastasis in human colorectal cancer.
Yamauchi T; Watanabe M; Hasegawa H; Nishibori H; Ishii Y; Tatematsu H; Yamamoto K; Kubota T; Kitajima M
Anticancer Res; 2003; 23(1A):245-9. PubMed ID: 12680220
[TBL] [Abstract][Full Text] [Related]
18. Cyclooxygenase-2 overexpression correlates with tumour recurrence, especially haematogenous metastasis, of colorectal cancer.
Tomozawa S; Tsuno NH; Sunami E; Hatano K; Kitayama J; Osada T; Saito S; Tsuruo T; Shibata Y; Nagawa H
Br J Cancer; 2000 Aug; 83(3):324-8. PubMed ID: 10917546
[TBL] [Abstract][Full Text] [Related]
19. Involvement of cyclooxygenase-derived prostaglandin E2 and nitric oxide in the protection of rat pancreas afforded by low dose of lipopolysaccharide.
Jaworek J; Bonior J; Tomaszewska R; Jachimczak B; Kot M; Bielański W; Pawlik WW; Sendur R; Stachura J; Konturek PC; Konturek SJ
J Physiol Pharmacol; 2001 Mar; 52(1):107-26. PubMed ID: 11321505
[TBL] [Abstract][Full Text] [Related]
20. A cyclooxygenase-2 (COX-2) selective non-steroidal anti-inflammatory drug enhances the growth inhibitory effect of butyrate in colorectal carcinoma cells expressing COX-2 protein: regulation of COX-2 by butyrate.
Crew TE; Elder DJ; Paraskeva C
Carcinogenesis; 2000 Jan; 21(1):69-77. PubMed ID: 10607736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]